Filing Details

Accession Number:
0001127602-18-010338
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-06 16:09:01
Reporting Period:
2018-03-02
Accepted Time:
2018-03-06 16:09:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1485966 A Carol Surface 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Svp, Chief Hr Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2018-03-02 12,000 $78.00 42,010 No 4 S Direct
Ordinary Shares Disposition 2018-03-05 12,479 $78.36 29,531 No 4 S Direct
Ordinary Shares Acquisiton 2018-03-05 24,719 $57.65 54,250 No 4 M Direct
Ordinary Shares Acquisiton 2018-03-05 22,706 $62.76 76,956 No 4 M Direct
Ordinary Shares Acquisiton 2018-03-05 1,195 $62.76 78,151 No 4 M Direct
Ordinary Shares Disposition 2018-03-05 40,338 $79.74 37,813 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2018-03-05 24,719 $0.00 24,719 $57.65
Ordinary Shares Stock Option (Right to Buy) Disposition 2018-03-05 22,706 $0.00 22,706 $62.76
Ordinary Shares Stock Option (Right to Buy) Disposition 2018-03-05 1,195 $0.00 1,195 $62.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,239 2023-10-28 No 4 M Direct
7,569 2024-07-28 No 4 M Direct
6,374 2024-07-28 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 1,092 Indirect 401(k)
Footnotes
  1. This balance increased by 140 shares due to exempt transactions such as dividend reinvestment.
  2. The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.340 to $78.440, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
  3. This option to purchase 32,958 New Medtronic ordinary shares for $57.65 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 32,958 Medtronic common stock shares for $57.65 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  4. This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  5. This option to purchase 30,275 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,275 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.